CORSET8 cells proliferate in vivo in response to Spike immunization or SARS-CoV-2 infection
A-B) Schematic set-up of the experiments. C) CTV dilution profile 4 days after intratracheal immunization with Spike/CpG or intramuscular immunization with Pfizer BNT162b2 vaccine. Quantification of the number of CORSET8 T cells and percentage of divided cells upon immunization with CpG control, Spike/CpG and Pfizer BNT162b2 vaccine. D) Mean fluorescence intensity (MFI) of several activation markers (CD44, CD69, IFN-γ, T-Bet) and percentage of Ki-67+ cells on both CORSET and endogenic CD45.2 T cells after i.t. and i.m. immunizations with Spike/CpG and Pfizer BNT162b2 vaccine, respectively. E) Schematic set-up of the experiment and gating on CD45.1+ CORSET8 cells in K18-hACE2wt/wt and K18-hACE2Tg/wt mice upon SARS-CoV-2 or mock infection. F) CTV dilution profile in SARS-CoV-2 infected K18-hACE2Tg/wt mice. G) Number of CORSET8 T cells in K18-hACE2wt/wt and K18-hACE2Tg/wt mice upon SARS-CoV-2 or mock infection. H) MFI of CD44 in CD45.1+ CORSET8 T cells and CD45.2+ T cells of recipient mice. I) MFI of Tetramer staining on CD45.1+ CORSET8 T cells and CD45.2+ endogenous Tetramer+ T cells. Data information: data are shown as means +/- SEM. In Fig. 4D, after assessing normality by a Shapiro-Wilk normality test, parametric data were analysed with a one-way ANOVA, whereas non-parametric data were analysed with a Kruskal-Wallis test. In Fig. 4H, after assessing normality by a Shapiro-Wilk normality test, non-parametric data were analysed with a Mann-Whitney test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. Data are representative of two independent experiments.